文献速递腹部CT

基于平扫CT图像诊断肝脂肪变的CT指标:在大型病理参考标准队列中制定并验证诊断截断值

CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
PubMed 文献 · Eur Radiol · 2018-12-19

在4413例活体肝供者候选者中,于平扫CT测量肝脏衰减(CTL)、肝脾衰减差(CTL-S)和肝脾衰减比(CTL/S),以病理诊断为参考,在3312例开发队列比较诊断效能并确定HS>33%的截断值(95%特异度和95%敏感度),在1101例测试队列验证;CTL-S诊断效能最高,HS>33%的AUC为0.926。

要点

  • CTL-S诊断HS≥5%和HS>33%的AUC分别为0.737和0.926,均高于CTL和CTL/S。
  • 120 kVp扫描时,CTL-S高特异度截断值-2.1诊断HS>33%的敏感度64.0%、特异度96.4%。
  • 120 kVp扫描时,CTL-S高敏感度截断值7.6诊断HS>33%的敏感度97.3%、特异度54.9%。

核心结论

  • 使用肝和脾衰减的CT指标诊断HS的效能高于仅用肝衰减的指标;本研究的CTL-S截断值可能有助于临床实践和研究中诊断HS。

研究设计与样本

  • 在4413例活体肝供者候选者(男2939例、女1474例,平均年龄31.4岁)的平扫CT图像上测量3种指标,以病理诊断为参考标准,在3312例开发队列用ROC分析比较诊断效能,在1101例测试队列验证截断值。

诊断标准与关键数值

  • CTL-S诊断HS≥5%和HS>33%的AUC分别为0.737和0.926。
  • CTL/S诊断HS≥5%和HS>33%的AUC分别为0.732和0.925。
  • CTL诊断HS≥5%和HS>33%的AUC分别为0.707和0.880。
  • 120 kVp扫描时,CTL-S截断值-2.1诊断HS>33%的敏感度64.0%、特异度96.4%。
  • 120 kVp扫描时,CTL-S截断值7.6诊断HS>33%的敏感度97.3%、特异度54.9%。

临床应用与阅片要点

  • 使用肝和脾衰减的CT指标(CTL-S、CTL/S)诊断HS的效能高于仅用肝衰减的CTL。
  • 本研究确定的CTL-S截断值可用于临床实践和研究中可靠诊断或排除中重度HS,包括活体肝供者筛选及HS或健康对照队列的建立。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the performances of CT indices for diagnosing hepatic steatosis (HS) and to determine and validate the CT index cut-off values.

METHODS: Three indices were measured on non-enhanced CT images of 4413 living liver donor candidates (2939 men, 1474 women; mean age, 31.4 years): hepatic attenuation (CTL), hepatic attenuation minus splenic attenuation (CTL-S), and hepatic attenuation divided by splenic attenuation (CTL/S). The performances of these CT indices in diagnosing HS, relative to pathologic diagnosis, were compared in the development cohort of 3312 subjects by receiver operating characteristic (ROC) analysis. The cut-off values for diagnosing HS > 33% in the development cohort were determined at 95% specificity and 95% sensitivity using bootstrap ROC analysis, and the diagnostic performance of these cut-off values was validated in the test cohort of 1101 subjects.

RESULTS: CTL-S showed the highest performance for diagnosing HS ≥ 5% and HS > 33% (areas under the curve (AUCs) = 0.737 and 0.926, respectively), followed by CTL/S (AUCs = 0.732 and 0.925, respectively) and CTL (AUCs = 0.707 and 0.880, respectively). For CT scans using 120 kVp, the CTL-S cut-off values for highly specific (i.e., - 2.1) and highly sensitive (i.e., 7.6) diagnosis of HS > 33% resulted in a specificity of 96.4% with a sensitivity of 64.0% and a sensitivity of 97.3% with a specificity of 54.9%, respectively, in the test cohort.

CONCLUSION: CT indices using liver and spleen attenuations have higher performance for diagnosing HS than indices using liver attenuation alone. The CTL-S cut-off values in this study may have utility for diagnosing HS in clinical practice and research.

KEY POINTS: • CT indices based on both liver attenuation and spleen attenuation (CTL-Sand CTL/S) have higher diagnostic performance than CTLbased on liver attenuation alone in diagnosing HS using various CT techniques. • The CT index cut-off values determined in this study can be utilized for reliable diagnosis or to rule out subjects with moderate to severe HS in clinical practice and research, including the selection of living liver donors and the development of cohorts with HS or healthy controls.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Byun J, Lee SS, Sung YS, et al. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard. Eur Radiol. 2018. PMID: 30569183. doi:10.1007/s00330-018-5905-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。